Liquid Biopsy Early Cancer Detection Diagnostics: The Current Landscape

Authors

Andrew Aijian

Partner

Related Insights

Clinical Diagnostics

The Platform & Service Model: Orion Spatial Biology and Circulating-Tumor Cell Liquid Biopsy DeciBio Q&A with Selena Larkin, CCO of RareCyte

Read our latest Q&A with Selena Larkin, CCO of RareCyte.

January 23, 2023

Clinical Diagnostics

Liquid Biopsy | December Roundup

Liquid Biopsy (LBx) had an active December, featuring distribution deals and debuted products as well as many trial and study results.

January 11, 2023

Clinical Diagnostics

Liquid Biopsy | November Roundup

Liquid Biopsy (LBx) had an active November, featuring distribution deals and debuted products as well as many trial and study results.

December 7, 2022

Clinical Diagnostics

Where Multiplex Meets Digital Pathology – DeciBio’s Q&A with James Mansfield

Read the latest Q&A as our experts speak with James Mansfield, Senior VP, Research Business Development at Visiopharm to discuss the intersection of multiplex tissue analysis and digital pathology.

November 29, 2022

View All Insights

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.